Arkolith/Insider Trading/AVXL/Form 4

Missling Christopher U

President and CEO, DirectorANAVEX LIFE SCIENCES CORP. (AVXL) · full profile →Form 4 · filed Apr 1, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$375K
Net Open-Market Flow
-$375K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2024Sell(S)73K$5.11$375K1.3M
Mar 28, 2024Option exercise(M)73K$1.32$97K1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 28, 2024Option exercise(M)73K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-24-000552) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML